My first reaction was where is the control group? Both groups are already undergoing treatment. To quote from the article:
"Design This study was a non-inferiority, randomized controlled clinical trial investigating the efficacy of EMDR treatment compared with CBT intervention in patients with recurrent depressive disorder already undergoing “treatment as usual” (TAU)." The CBT and EMDR were added on top of the TAU. How do we know whether CBT and EMDR had any added benefit beyond the TAU? Ken -- --------------------------------------------------------------------------------------------- Kenneth M. Steele, Ph.D. steel...@appstate.edu Professor Department of Psychology http://www.psych.appstate.edu Appalachian State University Boone, NC 28608 USA --------------------------------------------------------------------------------------------- On 2/20/2018 9:48 AM, Annette Taylor wrote: > > So I read this article and here are their results: > > "Sixty-six patients were analyzed as completers (31 EMDR vs. 35 CBT). > No significant difference between the two groups was found either at > the end of the interventions (71% EMDR vs. 48.7% CBT) or at the > 6-month follow-up (54.8% EMDR vs. 42.9% CBT). A RM-ANOVA on BDI-II > scores showed similar reductions over time in both groups [/F/(6,59) = > 22.501,/p/< 0.001] and a significant interaction effect between time > and group [/F/(6,59) = 3.357,/p/= 0.006], with lower BDI-II scores in > the EMDR group at T1 [mean difference = –7.309 (95% CI [–12.811, > –1.806]),/p =/0.010]. The RM-ANOVA on secondary outcome measures > showed similar improvement over time in both groups [/F/(14,51) = > 8.202,/p/< 0.001], with no significant differences between groups > [/F/(614,51) = 0.642,/p/= 0.817]. " > > And I would conclude: well the, USE CBT! It is more efficient and > cheaper and easier to use since you don't have to ADD a useless add-on > to CBT. But NO!!!!!!!!!! here is their conclusion: > > "this study suggests that EMDR could be a viable and effective > treatment for reducing depressive symptoms and improving the quality > of life of patients with recurrent depression. Trial registration: > ISRCTN09958202. " > > WHAT AM I MISSING HERE? I had a WTF moment here. Sorry if I'm being > dense at 6 am. Since tipsters are smart people perhaps you can > enlighten me. > > https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00074/full?utm_source=F-AAE&utm_medium=EMLF&utm_campaign=MRK_547424_69_Psycho_20180220_arts_A > > <https://www.frontiersin.org/articles/10.3389/fpsyg.2018.00074/full?utm_source=F-AAE&utm_medium=EMLF&utm_campaign=MRK_547424_69_Psycho_20180220_arts_A> > > Annette Kujawski Taylor, Ph.D. > Professor, Psychological Sciences > University of San Diego > 5998 Alcala Park > San Diego, CA 921210 > tay...@sandiego.edu <mailto:tay...@sandiego.edu> > > > --- You are currently subscribed to tips as: arch...@mail-archive.com. To unsubscribe click here: http://fsulist.frostburg.edu/u?id=13090.68da6e6e5325aa33287ff385b70df5d5&n=T&l=tips&o=52143 or send a blank email to leave-52143-13090.68da6e6e5325aa33287ff385b70df...@fsulist.frostburg.edu
